Clinical Trial

LAMBDA 002 (Lung Registry) Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The LAMBDA 002 registry study is an observational, longitudinal, multi-center study observing patients undergoing lung transplant.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-12-10; most recent amendment 2025-05-19.
Status change: Recruiting → Active, Not Recruiting 2024-03-19
Status change: Not Yet Recruiting → Recruiting 2023-03-29
Trial Details
NCT Number NCT05170425
Lead Sponsor Natera, Inc.
Conditions Lung Transplant Rejection
Enrollment 154 participants
Start Date 2022-11-04
Primary Completion 2026-08 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-05-22